What is iHear Medical?
iHear Medical operates within the OTC health and wellness sector, focusing on providing accessible solutions, particularly for individuals with hearing impairments. The company's product offerings, which include hearing aids, aim to empower seniors and the hearing-impaired by making health products readily available without prescription requirements. This strategic focus on a specific demographic and product category underscores its commitment to enhancing individual well-being through specialized health solutions.
How much funding has iHear Medical raised?
iHear Medical has raised a total of $9.6M across 5 funding rounds:
Series A
$475K
Series B
$1.8M
Series C
$5M
Debt
$2.3M
Debt
$70K
Series A (2010): $475K with participation from Aphelion Capital
Series B (2012): $1.8M, investors not publicly disclosed
Series C (2014): $5M supported by Ameritas Holding Company, Lighthouse Capital, and Aphelion Capital
Debt (2017): $2.3M featuring Ameritas Life Insurance Corp and Aphelion Capital
Debt (2021): $70K backed by PPP
Key Investors in iHear Medical
Aphelion Capital
Aphelion Capital is an investment firm that focuses on medical technology companies, aiming to improve healthcare quality and reduce costs. They are long-term investors, preferring private investments where they can actively partner with management teams.
Ameritas Life Insurance Corp
Ameritas is a mutual insurance company offering a range of insurance and financial services. Their investment in iHear Medical suggests a strategic interest in the health and wellness sector, potentially aligning with their broader mission to support individual well-being.
Lighthouse Capital
Lighthouse Capital appears to be involved in investment partnerships, contributing to the financial backing of companies like iHear Medical. Their participation indicates a role in facilitating growth capital for businesses within their investment scope.
What's next for iHear Medical?
With the recent influx of substantial expansion capital, iHear Medical is poised for significant scaling and market penetration. The company's trajectory suggests a strategic focus on enhancing its product development, expanding its distribution channels, and potentially exploring new markets or technological advancements in hearing health. The ongoing investment signifies strong confidence from backers in iHear Medical's business model and its potential for sustained growth and profitability in the competitive health-tech landscape.
See full iHear Medical company page
